Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
First Investment: 2017
HelixNano is developing new ways to manipulate messenger RNA, the molecule that delivers information from genes to the cell’s protein factories. One of HelixNano’s advances makes mRNA vaccines more targeted and more powerful; the company is using this technique to advance a mutation-resistant, second-generation vaccine against the SARS-CoV‑2 virus that causes Covid-19.
Explore Companies
Fourth Power
Building thermal energy storage technology to buffer the grid, as variable electricity sources replace polluting ones
Reality Defender
Stopping deepfakes before they become a problem
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing